Breaking News
Get 50% Off 0
🧩 Based on my current watchlist, how should I diversify my portfolio?
Ask WarrenAI
Close

Hoshi Iryo-Sanki Co Ltd (7634)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4,550.0 -5.0    -0.11%
08/08 - Closed. Currency in JPY
Type:  Equity
Market:  Japan
ISIN:  JP3845750003 
  • Volume: 2,800
  • Bid/Ask: 4,550.0 / 4,590.0
  • Day's Range: 4,500.0 - 4,560.0
Hoshi Iryo-Sanki 4,550.0 -5.0 -0.11%

Hoshi Iryo-Sanki Co Ltd Company Profile

 
Get an in-depth profile of Hoshi Iryo-Sanki Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

486

Equity Type

ORD

Hoshi Iryo-Sanki Co., Ltd. manufactures and sells pharmaceutical medical oxygen and nitrous oxides in Japan. It operates in five segments: Medical Gas Related Business; Home Medical Care Related Business; Medical Gas Equipment Construction Related Business; Nursing Care and Welfare Related Business; and Nursing Care Facility-Related Business. The Medical Gas Related Business segment sells medical oxygen gas, anesthetic gas, and other medical gases. The Home Medical Care Related Business segment rents and sells oxygen concentrators for home oxygen therapy, and continuous positive airway and sales. The Medical Gas Equipment Construction Related Business segment designs and constructs of medical gas piping works, as well as maintains and inspects of medical gas piping equipment. The Nursing Care and Welfare Related Business segment offers rental and sale of care and welfare related products and equipment, home renovation, visiting nursing, and home care support services. The Nursing Care Facility-Related Business segment operates the paid nursing homes and day care facilities, and other related operations. The company was founded in 1960 and is headquartered in Tokyo, Japan.

Contact Information

Address 7-11-18, Iriya Adachi-ku
Tokyo, 121-0836
Japan
Phone 81 3 3899 2101
Fax -

Top Executives

Name Age Since Title
Masanari Hoshi 89 2012 Executive Chairman of the Board of Directors
Yukio Hoshi 63 2005 President, CEO & Representative Director
Masahiro Hoshi 60 1994 Chief of President's Office, Senior MD & Director
Yukio Mogaki 63 2006 Senior MD, GM of Sales Div, Head of Tokyo, Kanagawa, Saitama, Nagano & Yamanashi Region & Director
Mitsuo Nukagari 59 2011 MD, Head of Hokkaido, Tohoku, Fukushima, Chiba & Ibaraki Region, Dy GM of Sales Div and Director
Eiji Kashu 64 2019 Director
Daisuke Tokunaga 51 2016 Director
Takanori Iizuka 57 2021 Independent Outside Director
Yuichi Yagi 44 2019 Independent Outside Director
Hajime Ishio 64 2009 Outside Audit & Supervisory Board Member
Takashi Tokuda 70 2009 Outside Audit & Supervisory Board Member
Keiichiro Aoki 64 2020 Full-Time Audit & Supervisory Board Member
Yasuyuki Suzuki 52 2010 Manager of Nagoya Branch & Director
Kazuhiro Hayamizu 60 2017 Manager of Medical Facility Business Department, Executive Officer & Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

7634 Comments

Write your thoughts about Hoshi Iryo-Sanki Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email